Hospital of the University of Pennsylvania

Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update

Retrieved on: 
Tuesday, November 7, 2023
Gene editing, Acute myeloid leukemia, Assistant, Doctor of Philosophy, Flexner Report, Data, Gene, HCT, Hospital, Research and development, Engineering, University, Hospital of the University of Pennsylvania, Patient, Administration, Transplant, DNA, Pediatric Transplantation, Congress, MD, G&A, Research, ASH, Clinical trial, Cytokine release syndrome, General Administration of Sport of China, Editas Medicine, CRS, Principal, Adolescence, IND, Manuscript, Harvard Medical School, Bone marrow, CRISPR, Phenotype, R, CD33, HERE, Toxicity, Associate, AML, Pharmaceutical industry, Dentistry, Vaccine, Nursing, Pediatrics, Gemtuzumab ozogamicin

CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period ended September 30, 2023, and provided a business update.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period ended September 30, 2023, and provided a business update.
  • Research & Development (R&D) Expenses: R&D expenses for the third quarter of 2023 were $27.6 million, compared to $16.9 million for the third quarter of 2022.
  • General & Administrative (G&A) Expenses: G&A expenses for the third quarter of 2023 were $7.7 million, compared to $7.2 million for the third quarter of 2022.
  • Net Loss: Net loss for the third quarter of 2023 was $33.2 million, compared to $23.8 million for the third quarter of 2022.

This university class uses color and emotion to explore the end of life

Retrieved on: 
Tuesday, August 22, 2023
Heart, Uncertainty, Technology, Communication, University, Student, Ars moriendi, Poetry, Education, Teaching, Silver, Emotion, MD Anderson Cancer Center, Phrase, Science, Creativity, Hospital of the University of Pennsylvania, Philosophy, Literature, Gold, Patient, Time, Love, Engineering, Ethics, Hospital, Course, Death, Color, Caregiver, Tutoring, Bookbinding, Nursing, Entertainment, Interior design, Life

In both contexts, I work with advanced oncology patients and with people at the end of life.

Key Points: 
  • In both contexts, I work with advanced oncology patients and with people at the end of life.
  • After decades working with university students and people facing the end of life, I found myself working with people at the beginning of life – with children.
  • The end of life is all about life itself and the many different types of love that we experience as human beings.
  • The class provides a window into a vital aspect of life that is often overlooked and avoided – namely, serious illness and the end of life.

NRC Health unveils winners of 2023 patient experience and loyalty awards

Retrieved on: 
Tuesday, August 8, 2023
New England Aquarium, New England, Success, Marital status, Mayo Clinic Hospital (Rochester), University, Beth Israel Deaconess Medical Center, National Research Corporation, Patient experience, NRC, Hospital, Health, Human, Sea, Organization, NPS, Hospital of the University of Pennsylvania, Missouri Baptist Medical Center, Community hospital, Monterey Peninsula, UC, The Christ Hospital, UC Davis Health Stadium, Patient, Lahey Hospital & Medical Center, California Hospital Medical Center, Christ Hospital, Parkview Health, Pharmaceutical industry, Nursing, Mercy, Troy

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

Key Points: 
  • LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.
  • NRC Health's Consumer Loyalty Award winners lead the way in delivering exceptional patient experiences.
  • Elevating the patient experience remains a priority in healthcare, and NRC Health's 2023 Excellence in Patient Experience Award winners have demonstrated outstanding commitment to individualized and human-centered care.
  • To check whether your local hospital is a 2023 honoree, see the full lists of winning organizations for both the 2023 Consumer Loyalty Awards and the 2023 Excellence in Patient Experience Awards .

NRC Health unveils winners of 2023 patient experience and loyalty awards

Retrieved on: 
Tuesday, August 8, 2023
New England Aquarium, New England, Success, Marital status, Mayo Clinic Hospital (Rochester), University, Beth Israel Deaconess Medical Center, National Research Corporation, Patient experience, NRC, Hospital, Health, Human, Sea, Organization, NPS, Hospital of the University of Pennsylvania, Missouri Baptist Medical Center, Community hospital, Monterey Peninsula, UC, The Christ Hospital, UC Davis Health Stadium, Patient, Lahey Hospital & Medical Center, California Hospital Medical Center, Christ Hospital, Parkview Health, Pharmaceutical industry, Nursing, Mercy, Troy

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

Key Points: 
  • LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.
  • NRC Health's Consumer Loyalty Award winners lead the way in delivering exceptional patient experiences.
  • Elevating the patient experience remains a priority in healthcare, and NRC Health's 2023 Excellence in Patient Experience Award winners have demonstrated outstanding commitment to individualized and human-centered care.
  • To check whether your local hospital is a 2023 honoree, see the full lists of winning organizations for both the 2023 Consumer Loyalty Awards and the 2023 Excellence in Patient Experience Awards .

CCRM Fertility Broadens North American Footprint By Adding The Advanced IVF Institute to its Network

Retrieved on: 
Wednesday, August 2, 2023
Advocate Lutheran General Hospital, Medicine, Reproductive medicine, University, Honors colleges and programs, Infertility, Parkland Memorial Hospital, Rosalind Franklin University of Medicine and Science, Research, Gynaecology, IVF, Hospital of the University of Pennsylvania, Fertility, Fertility preservation, MD, Patient, Physician, IIV, Fellow, Education minister, Obstetrics, Hospital, Immunology, AAGL, International Society, Birth control, Science, Northwestern University

CHICAGO, Aug. 2, 2023 /PRNewswire/ -- CCRM Fertility, a global pioneer in fertility treatment, research and science, has added The Advanced IVF Institute, to its rapidly expanding fertility treatment and family-building network. Dr. Charles Miller leads two Chicago-area locations and provides cutting-edge fertility treatments, including in vitro fertilization (IVF), fertility preservation and reproductive surgery.

Key Points: 
  • CHICAGO, Aug. 2, 2023 /PRNewswire/ -- CCRM Fertility , a global pioneer in fertility treatment, research and science, has added The Advanced IVF Institute , to its rapidly expanding fertility treatment and family-building network.
  • Dr. Charles Miller leads two Chicago-area locations and provides cutting-edge fertility treatments, including in vitro fertilization (IVF), fertility preservation and reproductive surgery.
  • For more than 35 years, CCRM Fertility has helped transform lives through exceptional fertility care.
  • As an internationally renowned expert in minimally invasive gynecologic surgery and in the treatment of infertility, Dr. Miller founded The Advanced IVF Institute in 2008.

Cardiovascular Implant Company PECA Labs Names Three New Board Members

Retrieved on: 
Tuesday, July 18, 2023
Health, Medical Devices, Cardiology, Barings Bank, Partnership, University, Raj Rajaratnam, Galleon Group, Anil Kumar, and Rajat Gupta insider trading cases, Wall Street, HUP, Heart, PwC, Yale School of Medicine, Galleon Group, Hospital of the University of Pennsylvania, Publication, Investment, Physician, PECA, UBS, Cowen, Hospital, Medtech, Cowen Inc., Management

The new board members will help guide the company as it develops and commercializes cardiovascular implants based on its novel tunable polymeric material platform.

Key Points: 
  • The new board members will help guide the company as it develops and commercializes cardiovascular implants based on its novel tunable polymeric material platform.
  • Dr. Carpenter is also a serial entrepreneur, including founding Embrella Cardiovascular, which was acquired by Edwards Lifesciences.
  • Jeffery O’Donnell, Sr. brings to PECA Labs more than 25 years of board and chief executive experience at emerging medical device companies.
  • O’Donnell founded and served as CEO for Trice Medical, and before that Embrella Cardiovascular, which was acquired by Edwards Lifesciences.

Dr. Thomas Hunt Appointed as Lee Health’s Vice President and Chief Physician Executive of Musculoskeletal Services

Retrieved on: 
Monday, July 17, 2023
Bachelor of Science in Nursing, Perioperative, University, Stanford University, Elective surgery, Arizona Cardinals, Health, Spine, University of Kansas Health System, Rehabilitation, Baylor St. Luke's Medical Center, Vanderbilt University School of Medicine, Disorder, Hospital of the University of Pennsylvania, National Association Medical Staff Services, Doctorate, Houston Texans, Physician, NBA, Injury, University of Kansas Medical Center, Joint, Hospital, American College, Hand, CommonSpirit Health, Safety, Nursing, Medicine

He is an experienced physician leader, orthopedic educator and clinical innovator, having published numerous articles, book chapters, textbooks, and delivered countless lectures and symposia.

Key Points: 
  • He is an experienced physician leader, orthopedic educator and clinical innovator, having published numerous articles, book chapters, textbooks, and delivered countless lectures and symposia.
  • Dr. Hunt also designed unique surgical implants used today for wrist fracture fixation as well as protocols permitting precise, remote and perioperative care.
  • His most recent clinical leadership positions include chief of the musculoskeletal service line at Baylor St. Luke’s Medical Center in Houston and chief physician executive for CommonSpirit Health’s Texas Division orthopedic service line.
  • We know he will be a huge asset to Southwest Florida,” said Dr. Iahn Gonsenhauser, Lee Health’s chief medical officer.

Median Technologies Announces Onboarding of All Academic Sites Involved in the Pivotal Validation Plan for iBiopsy® LCS CADe/CADx SaMD

Retrieved on: 
Monday, July 17, 2023
Health Technology, Other Health, Technology, Radiology, Oncology, Biometrics, Medical Devices, Hospitals, Clinical Trials, Science, Biotechnology, Software, Other Science, Health, Research, CE marking, Medical device, CT, MT, CMS, University, Brag, Centers for Medicare & Medicaid Services, Intervention, LCS, Journal of Thoracic Oncology, Cancer, Lung cancer, University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Lung, Pulmonology, MD Anderson Cancer Center, Medicare, MD, Lalit Vachani, Patient, Clinical research, MRMC, University of Pennsylvania Health System, Diagnosis, Hospital of the University of Pennsylvania, AI, Mortality, Hospital, FDA, Respiratory Medicine, Disease, Pharmaceutical industry, Medical imaging

For the purposes of its pivotal validation plan, Median Technologies has signed clinical research agreements with world-class academic healthcare institutions, which are leading healthcare centers for the management of lung cancer patients.

Key Points: 
  • For the purposes of its pivotal validation plan, Median Technologies has signed clinical research agreements with world-class academic healthcare institutions, which are leading healthcare centers for the management of lung cancer patients.
  • Median’s pivotal validation plan is composed of a pivotal standalone performance study (MT-LCS-002) and an international Multi-Reader Multi-Case (MRMC) pivotal clinical trial (MT-LCS-004).
  • Data quality is compulsory for the proper conduct of our pivotal validation plan” said Fredrik Brag, CEO and Founder of Median Technologies.
  • Now that we have onboarded all the sites, we are on track for the launch of our iBiopsy® LCS CADe/CADx SaMD pivotal validation plan.

Arbutus Appoints Two New Executives

Retrieved on: 
Monday, July 10, 2023
KRYS, Employment, University, Therapy, General counsel, Willamette University College of Law, HIV, Virology, Liz, Van Sweringen railroad holdings, Infection, Drug, Viral, Bristol Myers Squibb, Koch Industries, Doctor of Philosophy, Bates College, Assistant, BMY, Hospital of the University of Pennsylvania, Arbutus, Lung transplantation, Medical director, Patent, MD, Patient, Internal medicine, Oklahoma Office of the Chief Medical Examiner, Corporation, RNA interference, Hospital, Blank Rome, HCV, Hampden–Sydney College, HBV, NYSE, Behavioral neuroscience, Compensated emancipation, Pharmaceutical industry, Neuroscience, Medicine

WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Christopher Naftzger as General Counsel and Chief Compliance Officer. Mr. Naftzger succeeds Dr. Elizabeth Howard who will continue in an advisory role with respect to the on-going patent infringement litigations. Both Dr. Sims and Mr. Naftzger will report directly to William Collier, Arbutus President and Chief Executive Officer, effective immediately.

Key Points: 
  • Both Dr. Sims and Mr. Naftzger will report directly to William Collier, Arbutus President and Chief Executive Officer, effective immediately.
  • “Karen has played an integral role in the clinical development of AB-729, our lead RNAi therapeutic, during her six-year tenure at Arbutus, and has continued to advance our pipeline of HBV programs.
  • Prior to joining Arbutus, Dr. Sims held multiple positions during her seven-year tenure at Bristol-Myers Squibb (NYSE: BMY).
  • Christopher Naftzger joins Arbutus with more than 25 years of legal experience, including over a decade of experience serving as senior in-house counsel with life science companies.

RENOWNED PEDIATRIC HEART SURGEON JOINS MONTEFIORE EINSTEIN

Retrieved on: 
Monday, July 10, 2023
Boston Children's Hospital, Heart, Surgeon, University, Mathematics, Extracorporeal membrane oxygenation, Cone Health Women's Hospital, ECMO, Ventricular septal defect, Cardiology, Harvard University, Harvard Medical School, Social, Hospital of the University of Pennsylvania, Lung transplantation, CHAM, Pharmacist, Montefiore, Professor, MD, Patient, Division, Nursing, Fellow, Heart transplantation, Infant, Hospital, General surgery, Dentistry, Cardiothoracic surgery

NEW YORK, July 10, 2023 /PRNewswire/ -- Ibrahim Abdullah, M.D., has been recruited by Dr. Robert Michler to serve as the new Chief of the Division of Pediatric Cardiothoracic Surgery and Director of Pediatric Heart Transplantation & Pediatric Extracorporeal Membrane Oxygenation (ECMO) in the Department of Cardiothoracic & Vascular Surgery and the Montefiore Einstein Center for Heart & Vascular Care. He will also serve as Co-Director of the Pediatric Heart Center at the Children's Hospital at Montefiore (CHAM).

Key Points: 
  • NEW YORK, July 10, 2023 /PRNewswire/ -- Ibrahim Abdullah, M.D., has been recruited by Dr. Robert Michler to serve as the new Chief of the Division of Pediatric Cardiothoracic Surgery and Director of Pediatric Heart Transplantation & Pediatric Extracorporeal Membrane Oxygenation (ECMO) in the Department of Cardiothoracic & Vascular Surgery and the Montefiore Einstein Center for Heart & Vascular Care .
  • He will also serve as Co-Director of the Pediatric Heart Center at the Children's Hospital at Montefiore (CHAM).
  • This includes newborn heart surgery, complex anatomical conditions, lifesaving heart transplants and the management of children who need ECMO, in which a machine replaces the function of the heart and lungs when a patient's body is unable to do it themselves.
  • This is an exciting new chapter for Montefiore Einstein and for the community we serve."